WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Emil KuriakoseChief Medical Officer2025-04-01952$2.49
$2.37kSell
Jill M. QuigleyDirector2025-01-068,760$5.79
$50.76kSell
Mark J. VignolaChief Financial Officer2025-01-069,059$5.80
$52.50kSell
Emil KuriakoseChief Medical Officer2025-01-024,481$5.72
$25.61kSell
Mark J. VignolaChief Financial Officer2025-01-028,129$5.72
$46.52kSell
Jill M. QuigleyDirector2025-01-026,240$5.72
$35.70kSell
Amy L. BurroughsChief Executive Officer2024-12-0515,450$7.15
$110.47kBuy
Amy L. BurroughsChief Executive Officer2024-11-30510$5.11
$2.61kBuy
Melita Sun JungChief Business Officer2024-11-302,250$5.11
$11.50kBuy
Hongbo LuDirector2024-09-12285,714$10.50
$3.00MBuy

1 of 4

TERN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC13.22%11,536,701$27.69MInsider
Soleus Capital Management LP9.33%8,142,500$19.54MInstitution
Orbimed Advisors LLC8.66%7,562,971$18.15MInstitution
Vivo Capital LLC7.90%6,895,746$16.55MInstitution
Blackrock Inc6.58%5,743,482$13.78MInstitution
Deep Track Capital LP6.39%5,576,558$13.38MInstitution
Schonfeld Strategic Advisors LLC5.44%4,751,506$11.40MInstitution
Vanguard Group Inc4.43%3,869,582$9.29MInstitution
Morgan Stanley3.83%3,347,807$8.03MInstitution
Citadel Advisors LLC3.74%3,267,779$7.84MInstitution

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN80.94%19.06%Net BuyingNet Selling
SLDB35.72%64.28%Net BuyingNet Buying
ABEO41.85%58.15%Net SellingNet Selling
THRD66.17%33.83%Net Selling
ATXS80.96%19.04%
View Top Biotech Stocks

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 98.66% institutional shareholders, 23.24% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.54M shares representing 13.22% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $31.26M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.